Research Pipeline

Our research and development program is focused on what’s next. 

We discover, identify, and  objectively evaluate interventions of aging, to create new and more accurate predictive algorithms of disease, and to find better molecular predictors of clinical outcome, medication response and more.

You can view our current pipeline and ongoing research projects below.

Research & Development

Our R&D engine has both internal research capabilities and external partnerships is expected to deliver a steady stream of next-generation developments that will sustain our growth. These programs leverage new platform capabilities in multi-omics, data sciences, and more.

As you can see from our current research pipeline, there’s a lot happening behind the scenes at TruDiagnostic — and a lot to look forward to.

Our Research Timeline

Active Studies

Estimated Completion Date: August 2021 

Principle Investigator: Dr. Edwin Lee, MD

Estimated Completion Date: August 2021 

Principle Investigator: Dr. Hector Lopez, MD, CSCS, FAAPMR

Estimated Completion Date: December 2021 

Principle Investigator: Dr. Tavis Mendez, PhD

Estimated Completion Date: December 2021 

Principle Investigator: Dr. Tavis Mendez, PhD

Estimated Completion Date: September 2022

Principle Investigator: Dr. Jessica Lasky-Su

Estimated Completion Date: June 2022

Principle Investigator: Dr. Vincent Giampapa MD, FACS

Estimated Completion Date: November 2022

Principle Investigator: Dr. Tavis Mendez, Ph.D.

Estimated Completion Date: July 2022

Principle Investigator: Dr. Anthony Maffei

Estimated Completion Date: December 2021 

Principle Investigator: Dr. Julie Kissel, MD

Study Sponsor: QuickSilver 

Estimated Completion Date: June 2022 

Principle Investigator: Dr. Sanjeev Goel, MD

Study Sponsor:  TruDiagnostic LLC, Peak Human Labs

Estimated Completion Date: August 2021 

Principle Investigator: Dr. Tavis Mendez, PhD

Study Sponsor: TruDiagnostic LLC

Estimated Completion Date: November 2021 

Principle Investigator: Dr. James Foster

Study Sponsor: Preventative Medicine Research Group

Estimated Completion Date: March 2022 

Principle Investigator: Dr. Phillip Gallegos, MD

Study Sponsor:  Optigenex, Inc.

Estimated Completion Date: February 2022 

Principle Investigator:  Dr. Juergen Winkler, MD

Study Sponsor: Extended Longevity. Inc.